Health
Neanderthal-derived protein may reduce the severity of COVID-19 – Medical Xpress
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced…
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings are published today in Nature Medicine.
“Our analysis shows evidence that OAS1 has a protective effect against COVID-19 susceptibility and severity,” explains…
-
General17 hours agoCracks in the NACC. Brereton protected while corruption remains hidden
-
General21 hours agoJohn Cleese leads tributes to ‘perfect’ on-screen wife Prunella Scales
-
Noosa News24 hours agoCampfire sparks Teewah grassfire | Noosa Today
-
Noosa News23 hours agoSharks in feeding frenzy close to shore at world-renowned surf beach Snapper Rocks
